Testing effectiveness (Phase 2)Study completedNCT03136627
What this trial is testing
Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC
Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 28
Showing 20 of 0 results